Noureldine Salem I, Abbas Ali, Tufano Ralph P, Srivastav Sudesh, Slakey Douglas P, Friedlander Paul, Kandil Emad
Division of Head and Neck Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA,
Ann Surg Oncol. 2014 Aug;21(8):2733-9. doi: 10.1245/s10434-014-3610-0. Epub 2014 Mar 17.
The aim of this study was to evaluate the association between surgeon volume and patient outcomes among different race ethnicities undergoing thyroid or parathyroid surgery.
The nationwide inpatient sample was used to identify all thyroidectomy and parathyroidectomy admissions from 2003 to 2009, using International Classification of Diseases, 9th Clinical Modification (ICD-9-CM) procedure codes. Race, demographic, and clinical characteristics of patients were collected, along with surgeon volume, to predict the length of stay (LOS), complication rates, mortality, and total charges by racial group, using univariate and multivariate analyses.
A total of 106,314 thyroid and parathyroid surgeries were included in the current analysis. Of these patients, 54 % were Caucasian, 11 % African American, 7 % Hispanic, and 3 % Asian. Mean LOS was longer for African American patients (4 ± 8.7 days) than for Caucasians (2.3 ± 5.5 days) [p < 0.001]. African Americans had higher overall complications (16.8 %) compared with Caucasians (11 %), Hispanics (13.5 %), and Asians (12 %) [p < 0.001]. In-hospital mortality was higher for African Americans (0.8 %) compared with that from other race groups (0.3 %) [p < 0.001]. Mean total charges were significantly higher for African Americans ($33,292 ± $67,387) compared with those for Caucasians ($22,855 ± $40,167) (p < 0.001). African Americans had less access to intermediate- (10-99 cases) and high- (>100 cases) volume surgeons compared with Caucasians-45 versus 49 %, and 16 versus 19 %, respectively (p < 0.001). Higher surgeon volume was associated with improved outcomes (p < 0.001). Racial disparity in all investigated outcomes was still significantly evident even after stratification by surgeon volume.
Higher surgeon volume is associated with improved patient outcomes. However, our data suggests that the observed racial disparities in thyroid and parathyroid surgery go beyond access to quality healthcare providers.
本研究旨在评估接受甲状腺或甲状旁腺手术的不同种族患者中,外科医生手术量与患者预后之间的关联。
利用全国住院患者样本,通过国际疾病分类第九版临床修订本(ICD - 9 - CM)程序编码,识别出2003年至2009年期间所有甲状腺切除术和甲状旁腺切除术的住院病例。收集患者的种族、人口统计学和临床特征以及外科医生手术量,采用单因素和多因素分析方法,按种族分组预测住院时间(LOS)、并发症发生率、死亡率和总费用。
本分析共纳入106,314例甲状腺和甲状旁腺手术病例。其中,54%为白人,11%为非裔美国人,7%为西班牙裔,3%为亚裔。非裔美国患者的平均住院时间(4 ± 8.7天)长于白人患者(2.3 ± 5.5天)[p < 0.001]。与白人(11%)、西班牙裔(13.5%)和亚裔(12%)相比,非裔美国人的总体并发症发生率更高(16.8%)[p < 0.001]。非裔美国人的院内死亡率(0.8%)高于其他种族组(0.3%)[p < 0.001]。非裔美国人的平均总费用(33,292美元 ± 67,387美元)显著高于白人(22,855美元 ± 40,167美元)(p < 0.001)。与白人相比,非裔美国人获得中级手术量(10 - 99例)和高手术量(>100例)外科医生治疗的机会更少,分别为45%对49%以及16%对19%(p < 0.001)。外科医生手术量越高,预后越好(p < 0.001)。即使按外科医生手术量分层后,所有研究结果中的种族差异仍然显著。
外科医生手术量越高,患者预后越好。然而,我们的数据表明,在甲状腺和甲状旁腺手术中观察到的种族差异不仅仅在于获得高质量医疗服务提供者的机会。